Literature DB >> 23578931

miR-21 represses Pdcd4 during cardiac valvulogenesis.

Heather J Kolpa1, David S Peal, Stacey N Lynch, Andrea C Giokas, Shibnath Ghatak, Suniti Misra, Russell A Norris, Calum A Macrae, Roger R Markwald, Patrick Ellinor, Joyce Bischoff, David J Milan.   

Abstract

The discovery of small non-coding microRNAs has revealed novel mechanisms of post-translational regulation of gene expression, the implications of which are still incompletely understood. We focused on microRNA 21 (miR-21), which is expressed in cardiac valve endothelium during development, in order to better understand its mechanistic role in cardiac valve development. Using a combination of in vivo gene knockdown in zebrafish and in vitro assays in human cells, we show that miR-21 is necessary for proper development of the atrioventricular valve (AV). We identify pdcd4b as a relevant in vivo target of miR-21 and show that protection of pdcd4b from miR-21 binding results in failure of AV development. In vitro experiments using human pulmonic valve endothelial cells demonstrate that miR-21 overexpression augments endothelial cell migration. PDCD4 knockdown alone was sufficient to enhance endothelial cell migration. These results demonstrate that miR-21 plays a necessary role in cardiac valvulogenesis, in large part due to an obligatory downregulation of PDCD4.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578931      PMCID: PMC3640220          DOI: 10.1242/dev.084475

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  53 in total

1.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.

Authors:  Luika A Timmerman; Joaquín Grego-Bessa; Angel Raya; Esther Bertrán; José María Pérez-Pomares; Juan Díez; Sergi Aranda; Sergio Palomo; Frank McCormick; Juan Carlos Izpisúa-Belmonte; José Luis de la Pompa
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

2.  MicroRNA expression in zebrafish embryonic development.

Authors:  Erno Wienholds; Wigard P Kloosterman; Eric Miska; Ezequiel Alvarez-Saavedra; Eugene Berezikov; Ewart de Bruijn; H Robert Horvitz; Sakari Kauppinen; Ronald H A Plasterk
Journal:  Science       Date:  2005-05-26       Impact factor: 47.728

3.  Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430.

Authors:  Wen-Yee Choi; Antonio J Giraldez; Alexander F Schier
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

4.  CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.

Authors:  Y U Katagiri; J Sleeman; H Fujii; P Herrlich; H Hotta; K Tanaka; S Chikuma; H Yagita; K Okumura; M Murakami; I Saiki; A F Chambers; T Uede
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

5.  Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.

Authors:  A B Tuck; D M Arsenault; F P O'Malley; C Hota; M C Ling; S M Wilson; A F Chambers
Journal:  Oncogene       Date:  1999-07-22       Impact factor: 9.867

6.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

7.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

8.  Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation.

Authors:  Jeroen Bakkers; Carina Kramer; Joris Pothof; Nicolette E M Quaedvlieg; Herman P Spaink; Matthias Hammerschmidt
Journal:  Development       Date:  2004-02       Impact factor: 6.868

9.  SMAD proteins control DROSHA-mediated microRNA maturation.

Authors:  Brandi N Davis; Aaron C Hilyard; Giorgio Lagna; Akiko Hata
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

10.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

View more
  7 in total

1.  Quantitative Proteomics Analysis Reveals Novel Targets of miR-21 in Zebrafish Embryos.

Authors:  Ying Wu; Qi-Yong Lou; Feng Ge; Qian Xiong
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

2.  MicroRNA Expression Signature in Human Calcific Aortic Valve Disease.

Authors:  Hui Wang; Jing Shi; Beibei Li; Qiulian Zhou; Xiangqing Kong; Yihua Bei
Journal:  Biomed Res Int       Date:  2017-04-11       Impact factor: 3.411

Review 3.  Insights into role of microRNAs in cardiac development, cardiac diseases, and developing novel therapies.

Authors:  Maedeh Arabian; Fatemeh Mirzadeh Azad; Majid Maleki; Mahshid Malakootian
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

4.  Atheroprotective pulsatile flow induces ubiquitin-proteasome-mediated degradation of programmed cell death 4 in endothelial cells.

Authors:  Cheng Ge; Jiantao Song; Liang Chen; Lin Wang; Yifei Chen; Xinxin Liu; Yu Zhang; Lining Zhang; Mei Zhang
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

Review 5.  The zebrafish as a tool to identify novel therapies for human cardiovascular disease.

Authors:  Aarti Asnani; Randall T Peterson
Journal:  Dis Model Mech       Date:  2014-07       Impact factor: 5.758

Review 6.  Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death.

Authors:  J Skommer; I Rana; F Z Marques; W Zhu; Z Du; F J Charchar
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

7.  Mutations in DCHS1 cause mitral valve prolapse.

Authors:  Ronen Durst; Kimberly Sauls; David S Peal; Annemarieke deVlaming; Katelynn Toomer; Maire Leyne; Monica Salani; Michael E Talkowski; Harrison Brand; Maëlle Perrocheau; Charles Simpson; Christopher Jett; Matthew R Stone; Florie Charles; Colby Chiang; Stacey N Lynch; Nabila Bouatia-Naji; Francesca N Delling; Lisa A Freed; Christophe Tribouilloy; Thierry Le Tourneau; Hervé LeMarec; Leticia Fernandez-Friera; Jorge Solis; Daniel Trujillano; Stephan Ossowski; Xavier Estivill; Christian Dina; Patrick Bruneval; Adrian Chester; Jean-Jacques Schott; Kenneth D Irvine; Yaopan Mao; Andy Wessels; Tahirali Motiwala; Michel Puceat; Yoshikazu Tsukasaki; Donald R Menick; Harinath Kasiganesan; Xingju Nie; Ann-Marie Broome; Katherine Williams; Amanda Johnson; Roger R Markwald; Xavier Jeunemaitre; Albert Hagege; Robert A Levine; David J Milan; Russell A Norris; Susan A Slaugenhaupt
Journal:  Nature       Date:  2015-08-10       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.